Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma
0 Views
administrator
07/18/23
The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.
-
Category
Show more
Facebook Comments
No comments found